Emerson is a global technology and engineering company providing innovative solutions for customers in industrial, commercial, and residential markets. Our Emerson Automation Solutions business helps process, hybrid, and discrete manufacturers maximize production, protect personnel and the environment while optimizing their energy and operating costs. Our Emerson Commercial & Residential Solutions business helps ensure human comfort and health, protect food quality and safety, advance energy efficiency, and create sustainable infrastructure. For more information visit Emerson.com.
Our new Single-Use technology provides the same proven stability and performance as traditional stainless steel technologies and are uniquely adapted to fully meet the needs of the Single-Use biopharmaceutical manufacturing environment. Learn how the Rosemount™ 550pH Single-Use Sensor and 550DW Single-Use Dissolved Oxygen Sensor can provide greater measurement stability, reduce risk in process quality, and achieve immediate start-up.
6021 Innovation Blvd
Shakopee, MN 55379
Phone: 952 204 4062
Contact: Ben Arriola
As single-use manufacturing methods continue to take hold throughout the upstream and downstream biopharmaceutical sectors, improved instrumentation options are developing in parallel to meet the unique needs of single-use processes while reducing costs and maintaining performance.
Consistent and repeatable batch operations are key to productivity in pharmaceutical and biotech processes. This white paper explores how typical pharmaceutical and biotech manufacturing batch operations depend on fundamental process parameters. It shows the importance of precision and repeatability, and describes how reliable, accurate instrumentation allows automation to support quality and productivity strategies such as the process analytical technology (PAT) initiative, continued process verification (CPV), and the ICH Q10 Pharmaceutical Quality System.
Emerson’s Rosemount™ 550pH sensor and Rosemount 550DW dissolved oxygen sensor adapter meet the needs of the rapidly growing biopharmaceutical single-use market